openPR Logo
Press release

Increasing use of Metabolomics as Key Tool in Life Sciences To Boost Global Metabolomics Market to US$2.50 bn by 2024

11-04-2016 02:32 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Increasing use of Metabolomics as Key Tool in Life Sciences

Metabolomics help in the identification and quantification of cellular metabolites by using refined analytical technologies coupled with multi-variant and statistics methods. Metabolomics are used for data mining and for providing functional information of the physiological nature of an organism.

Over the past few years, many analytical technologies have been introduced and employed to study metabolites in various organisms, fluids, and tissues. Thanks to the increasing application of metabolomics such as the identification of gene function, monitoring responses to abiotic and biotic stress, and phenotyping of genetically modified plants, the demand for metabolomics is expected to increase in the years to come.

Download Exclusive Sample of this Report: http://bit.ly/2foCUiz

The global metabolomics market is expected to expand at a 17.10% CAGR during the period from 2016 to 2024 to reach US$2.50 bn by 2024. Factors such as the increasing application of metabolomics, the increasing use of metabolomics as a tool in life science, and the increased government spending are expected to propel the global metabolomics market in the near future.

High-performance Liquid Chromatography (HPLC) to Dominate Global Metabolomics Market

The global metabolomics market is segmented on the basis of technique, region, and application. By technique, the global metabolomics market is classified into detection techniques and separation techniques. Gas chromatography, high-performance liquid chromatography (HPLC), and capillary electrophoresis are some of the types of separation techniques. Currently, HPLC dominates the global metabolomics market.

The rapid growth registered by pharmaceutical and biotechnology sectors is expected to propel the global metabolomics market in the next few years. Further, factors such as the rising demand for customized medicines, growing government funding, improved research and development technologies, and the growing need for toxicology testing technologies are expected to benefit the global metabolomics market. However, the lack of skilled professionals in metabolomics science is predicted to restrict the growth of the global metabolomics market in the near future.

By region, the global metabolomics market is divided into North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America. Thermo Fisher Scientific, Inc. (U.S.), Biocrates Life Sciences AG (Austria), Waters Corporation (U.S.), LECO Corporation (U.S.), Bio-Rad Laboratories, Inc.(U.S.), Agilent Technologies, Inc.(U.S.), Shimadzu Corporation (Japan), Human Metabolome Technologies, Inc.(Japan), Metabolon, Inc. (U.S.), and Bruker Corporation (U.S.) are some of the key companies operating in the global metabolomics market.

Increasing Use of Metabolomics in Life Sciences Marks Next Major Opportunity

Metabolomics is used to bridge the gap between phenotype and genotype by offering a complete view of functioning of cells. In life science, metabolomics is used as an important tool as it is a relatively precise and faster technique than many others. Metabolomics as a tool in life science can be applied with a particular focus to gain new information about biological systems.

Browse Research Report: http://bit.ly/2elfdXP

In today’s era of scientific advances, technological developments, and new research methodologies, customized health care provides valuable information to identify and detect the start of various diseases at their early stages. This prevents the development of diseases, thereby increasing the effectiveness of health care systems by enhancing availability, quality, and affordability. The high occurrence of chronic degenerative diseases such as cancer and cardiovascular diseases, especially in developed nations, is expected to propel the global metabolomics market in the near future.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Increasing use of Metabolomics as Key Tool in Life Sciences To Boost Global Metabolomics Market to US$2.50 bn by 2024 here

News-ID: 379220 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Metabolomics

Emerging Trends Influencing The Growth Of The Metabolomics Services Market: Inno …
The Metabolomics Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Metabolomics Services Market Size Expected to Be by 2034? The metabolomics services market size will grow from $2.65 billion in 2024 to $3.04 billion in 2025 at a compound annual growth
Major Market Shift in Metabolomics Services Industry: Innovative Diagnostic Tool …
"What Is the Forecasted Market Size and Growth Rate for the Metabolomics Services Market? The scale of the metabolomics services market has rapidly expanded in the last few years. It is projected to surge from $2.65 $ billion in 2024 to $3.04 $ billion in 2025, representing a compound annual growth rate (CAGR) of 14.7%. This growth during the historical span is the result of a greater emphasis on biomarker discovery,
Coverage: Metabolomics Market covers analysis By Products and Services (Metabolo …
Metabolomics is the study of small molecules which resides in cells, biofluids, and tissues. The studies are extensively conducted with an aim to analyze biochemical activities of these small molecules and their interactions with biological systems. Metabolomics has wide variety of applications in disease diagnosis, drug discovery, enzyme discovery, and others. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00008670?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: Thermo Fisher Scientific Inc. Waters Corporation Agilent Technologies, Inc. Human Metabolome Technologies, Inc. Bruker Corporation Shimadzu Corporation PerkinElmer Metabolon, Inc. Leco Corporation Hitachi
Metabolomics Market: Partnerships and investments to speed up development of met …
In the field of precision medicine, metabolomics has been playing a crucial part and emerging as a vital tool. The analysis of metabolites such as amino acids, sugars, and lipids within biological systems can be utilized for diagnosing various types of diseases such as cancer, depression, and others. Market players have adopted various strategies such as partnership and raising funding to accelerate the development of products. Request Sample Report at:
Metabolomics Market: Future Demand and Growth Analysis
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules and their interactions in a biological system are known as the metabolome. Metabolomics involves the study of substrates and products of metabolism, which are affected by genetic and environmental factors. With the increasing applications of metabolomics in life sciences, the demand is increasing gradually. Metabolomics is gaining more
Metabolomics Market : Future of Metabolomics Dependent on Biomarker Discovery an …
According to a new market report published by Transparency Market Research “Metabolomics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024”, the metabolomics market is anticipated to expand at a CAGR of 17.1% from 2016 to 2024 to reach USD 2,494.8 million by 2024. Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules